CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00350-06v1
14/3/299    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramírez-Pfeiffer, C.
Right arrow Articles by Gomez-Flores, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramírez-Pfeiffer, C.
Right arrow Articles by Gomez-Flores, R.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, March 2007, p. 299-303, Vol. 14, No. 3
1071-412X/07/$08.00+0     doi:10.1128/CVI.00350-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Application of the Fluorescence Polarization Assay for Detection of Caprine Antibodies to Brucella melitensis in Areas of High Prevalence and Widespread Vaccination{triangledown}

C. Ramírez-Pfeiffer,1,4 K. Nielsen,2 P. Smith,2 F. Marín-Ricalde,3 C. Rodríguez-Padilla,4 and R. Gomez-Flores4*

Instituto Nacional de Investigaciones Forestales y Agropecuarias, Campo Experimental Río Bravo, Río Bravo, Tamaulipas, México,1 Ottawa Laboratories, Fallowfield, Canadian Food Inspection Agency, 3851 Fallowfield Road, Nepean, Ontario K2H 8P9, Canada,2 Comité para el Fomento y Protección Pecuaria de Nuevo León, Laboratorio Central Regional de Monterrey, Terrenos Exposición Ganadera, Guadalupe, Nuevo León, México,3 Universidad Autónoma de Nuevo León, Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, San Nicolás de los Garza, Nuevo León, México4

Received 26 September 2006/ Returned for modification 8 November 2006/ Accepted 2 January 2007

The screening Rose Bengal test (RBT), the buffered plate agglutination test (BPAT), and the confirmatory complement fixation test (CFT) are currently approved by the World Organization for Animal Health (OIE) for diagnosis of goat brucellosis. However, RBT (at 3% or 8% cell concentration) is known to be affected by vaccinal antibodies. In the present study, Mexican and Canadian OIE tests were compared with the fluorescence polarization assay (FPA), alone or in combination, using indirect and competitive enzyme-linked immunosorbent assays as classification variables for goat sera obtained from an area of high prevalence and widespread vaccination. The relative sensitivities and specificities were, respectively, 99.7% and 32.5% for RBT3, 92.8% and 68.8% for RBT8, 98.4% and 84.8% for Canadian CFT, 83.7% and 65.5% for Mexican CFT, and 78.1% and 89.3% for FPA. The use of FPA as the confirmatory test in combination with other tests significantly increased the final specificities of the screening tests alone; BPAT, RBT3, and RBT8 plus FPA resulted in final specificities of 90%, 91.2%, and 91.3%, respectively, whereas for the combinations RBT3 plus Mexican CFT, RBT8 plus Mexican CFT, and BPAT plus Canadian CFT, specificities were 65.5%, 63.2%, and 91.7%, respectively. We suggest that FPA may be routinely applied as an adaptable screening test for diagnosis of goat brucellosis and as a confirmatory test for screening test series. Some advantages of FPA are that its cutoff can be adjusted to improve its sensitivity or specificity, it is a low-cost and easy-to-perform test of choice when specificity is relevant or when an alternative confirmatory test is not available, and it is not affected by vaccination, thus reducing the number of misdiagnosed and killed goats.


* Corresponding author. Mailing address: Río Guadalquivir 401-B Ote., Colonia del Valle, San Pedro Garza García, Nuevo León, México, C.P. 66220. Phone: (52) 83 29-41-10, ext. 6453. Fax: (52) 83 52-42-12. E-mail: rgomez60{at}hotmail.com.

{triangledown} Published ahead of print on 31 January 2007.


Clinical and Vaccine Immunology, March 2007, p. 299-303, Vol. 14, No. 3
1071-412X/07/$08.00+0     doi:10.1128/CVI.00350-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.